ModuLight

Restoring Balance, Transforming Neurology

Boston, Israel · Founded 2022 · $12.2M raised

Headquarters
Boston
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$12.2M
Last Round
$12.2M SeedNov 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 8 investors for this company. The full record is or through the API.

About

ModuLight develops a precision neuromodulation platform using light and optogenetics for people living with severe neurological disorders. Its first planned indication for clinical studies is debilitating neuropathic pain, targeting the trigeminal nerve with light therapy. Its mission includes helping patients regain function and comfort by addressing seizures, tremors, and persistent pain.

Summary

ModuLight is a Biotech company based in Boston, Israel, founded in 2022. It has raised $12.2M in total across 1 round, most recently a $12.2M Seed round in Nov 2025. Investors include Jib Ventures, LocalGlobe and Nexus NeuroTech Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedNov 2025
$12.2M

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ModuLight on Indexed.vc
<a href="https://indexed.vc/companies/modulight"><img src="https://indexed.vc/api/badge/company/modulight" alt="ModuLight on Indexed.vc" width="260" height="76" /></a>